Piramal Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	12,236	3,889	3,714	1,956	2,281
Short-Term Investments	-	-	-	-	1	7.1
Trading Asset Securities	-	1,318	195.6	1,447	4,271	504
Cash & Short-Term Investments	13,554	13,554	4,085	5,160	6,228	2,792
Cash Growth	231.80%	231.80%	-20.84%	-17.14%	123.06%	-28.00%
Accounts Receivable	-	22,105	23,757	21,348	18,144	18,086
Other Receivables	-	433.4	453.7	171.3	35.6	141.9
Receivables	-	22,539	24,211	21,519	18,179	18,228
Inventory	-	30,644	23,127	21,759	16,814	13,888
Prepaid Expenses	-	977.4	791.8	640.2	765.7	695.5
Restricted Cash	-	-	1,125	1,112	1,021	913.5
Other Current Assets	-	4,202	4,630	4,454	5,347	4,155
Total Current Assets	-	71,917	57,970	54,645	48,355	40,672
Property, Plant & Equipment	-	56,419	50,235	48,160	44,415	37,157
Long-Term Investments	-	2,442	2,268	2,403	2,119	2,168
Goodwill	-	12,574	11,482	11,226	11,075	10,305
Other Intangible Assets	-	28,845	29,386	31,672	33,382	33,053
Long-Term Accounts Receivable	-	-	-	-	18.6	750.6
Long-Term Deferred Tax Assets	-	5,147	3,931	3,865	3,493	2,973
Other Long-Term Assets	-	2,307	1,504	1,149	2,369	892
Total Assets	-	179,650	156,776	153,118	145,226	127,970

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	-	24,791	15,338	15,384	11,927	10,264
Accrued Expenses	-	2,574	2,991	2,448	2,642	2,141
Short-Term Debt	-	7,478	9,953	11,714	13,023	6,588
Current Portion of Long-Term Debt	-	4,477	5,109	9,037	8,189	7,424
Current Portion of Leases	-	436.8	370.4	333.1	303.9	184.4
Current Income Taxes Payable	-	105.5	96.1	403	35.4	716.6
Current Unearned Revenue	-	42.3	45	19.6	859	452.7
Other Current Liabilities	-	7,678	3,760	4,355	1,451	2,564
Total Current Liabilities	-	47,583	37,663	43,693	38,431	30,333
Long-Term Debt	-	43,000	32,141	24,838	33,835	26,221
Long-Term Leases	-	1,728	991.6	1,180	1,019	862
Long-Term Unearned Revenue	-	300.2	295.1	238	335.6	460.3
Pension & Post-Retirement Benefits	-	569.2	486.6	322.3	205.9	125.1
Long-Term Deferred Tax Liabilities	-	3,582	2,484	2,292	2,193	1,920
Other Long-Term Liabilities	-	1,262	1,461	1,442	1,471	1,082
Total Liabilities	-	98,024	75,521	74,004	77,491	61,004

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	-	13,272	13,244	13,230	11,933	11,859
Additional Paid-In Capital	-	47,683	47,372	47,249	38,187	37,252
Retained Earnings	-	6,919	10,493	9,707	9,564	11,589
Comprehensive Income & Other	-	13,752	10,146	8,928	8,050	6,267
Shareholders' Equity	81,626	81,626	81,255	79,114	67,735	66,966
Total Liabilities & Equity	-	179,650	156,776	153,118	145,226	127,970

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	57,120	57,120	48,565	47,102	56,371	41,279
Net Cash (Debt)	-43,566	-43,566	-44,480	-41,941	-50,143	-38,487
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-32.77	-32.87	-33.43	-32.68	-42.13	-32.65
Filing Date Shares Outstanding	1,334	1,327	1,324	1,323	1,193	1,186
Total Common Shares Outstanding	1,334	1,327	1,324	1,323	1,193	1,186
Working Capital	-	24,334	20,307	10,952	9,924	10,339
Book Value Per Share	61.50	61.50	61.35	59.80	56.76	56.47
Tangible Book Value	40,207	40,207	40,386	36,216	23,278	23,608
Tangible Book Value Per Share	30.30	30.30	30.50	27.38	19.51	19.91
Land	-	2,002	1,792	1,729	1,339	1,300
Buildings	-	22,426	20,380	18,949	15,260	11,996
Machinery	-	55,134	47,560	41,626	36,473	30,662
Construction In Progress	-	7,992	4,891	5,657	8,529	6,732